Skip to content

Effectiveness of Syzygium jambolanum and individualized homeopathic in the management of type 2 diabetes mellitus.

Assessing the effectiveness of Syzygium jambolanum and individualized homeopathic medicine in fifty millesimal potency and centesimal potency in the management of type 2 diabetes mellitus - A comparitive study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102197
Enrollment
100
Registered
2026-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Syzygium jambolanum and individualised remedy in Fifty millesimal potency and centesimal potency: A total of 100 subjects diagnosed with Type 2 Diabetes Mellitus will be enrolled in the

Sponsors

Government homoeopathic medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Subjects who are willing to participate as volunteers and have signed the written informed consent. 2 Subjects between the age group of 35 to 65 years. 3 New cases of Type II Diabetes mellitus without any previous medicinal intervention diagnosed on the basis of ICMR Criteria. 4 Subjects diagnosed with diabetes mellitus and having HbAlc up to 9

Exclusion criteria

Exclusion criteria: 1 Subjects with complications of Diabetes mellitus such as Diabetic Neuropathy, Retinopathy or Gangrene. 2. Subjects under chronic medication for any other systemic illness like Pancreatitis Hypothyroidism Hyperthyroidism Hypertension. 3. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Outcome will be assessed by evaluating HbA1c levels less than 6.5Timepoint: 1. The follow up of the cases will be done for a period of six months once in a month. 2. Glycated Hemoglobin (HbAlc) will be tested at the baseline third month and sixth month.

Secondary

MeasureTime frame
Syzygium jambolanum and individualized homeopathic medicine will be assessed based on fifty millesimal potency and centesimal potency to assess which is more effective in the treatment of diabetes meritus As in potency and also between Syzygium and individualized homeopathic medicineTimepoint: 1. The follow up of the cases will be done for a period of six months once in a month. 2. Glycated Hemoglobin (HbAlc) will be tested at the baseline third month and sixth month.

Countries

India

Contacts

Public ContactDr Rachitha Shankar B

Government homoeopathy medical college and hospital

dr.shobha.malipatil@gmail.com9663998981

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026